原发性肝平滑肌肉瘤的CT检查影像学特征
CT features of primary liver leiomyosarcoma
-
摘要:目的 探讨原发性肝平滑肌肉瘤(PHLMS)的CT检查影像学特征。方法 采用回顾性描述性研究方法。收集2011年1月至2020年12月4家医学中心温州市中心医院(3例)、温州医科大学附属二院(3例)、温州市人民医院(2例)、乐清市人民医院(2例)收治的10例PHLMS病人的临床影像资料;男5例,女5例;中位年龄为55岁,年龄范围为41~83岁。病人均行腹部CT检查。观察指标:(1)CT检查情况。(2)治疗和病理学检查结果。(3)随访和生存情况。术后采用门诊、住院及影像学检查方式进行随访,了解病人肿瘤复发及病情稳定情况等,随访时间截至2020年12月。偏态分布的计量资料以M(范围)表示。计量资料以绝对数表示。结果 (1)CT检查情况:10例病人均为单发肿瘤,其中肿瘤位于肝左叶3例,肝右叶7例。10例病人肿瘤长径为8.0 cm(4.5~13.5 cm)。10例病人CT检查平扫结果示7例肿瘤膨胀性生长,呈圆形或椭圆形,界限清楚,肿瘤实质部分呈不均匀低密度,中央见斑片状更低密度区;3例肿瘤浸润性生长,呈斑片状,界限不清楚,肿瘤实质均匀等密度。10例病人CT值为40 HU(23~47 HU)。10例病人中,7例肿瘤膨胀性生长病人CT检查增强扫描动脉期结果示肿瘤实质部分呈不均匀轻度强化3例,不均匀中度强化3例,不均匀显著强化1例;7例病人CT值为68 HU(62~88 HU)。3例肿瘤浸润性生长病人CT检查增强扫描动脉期结果示周边强化明显强于中央区,3例病人CT值为73 HU(67~90 HU)。10例病人中,7例肿瘤膨胀性生长病人CT检查增强扫描门静脉期结果示肿瘤实质部分呈持续渐进性轻、中度强化,密度不均匀,CT值为63 HU(55~78 HU),其中3例肿瘤强化范围扩大,呈融合充填趋势;4例肿瘤中心及周边小片状或结节状强化和网格样强化。3例肿瘤浸润性生长病人CT检查增强扫描门静脉期结果示强化退出,密度不均匀,中位CT值为58 HU(50~62 HU)。10例病人CT检查增强扫描延迟期结果示肿瘤内强化缓慢退出,中位CT值为53 HU(50~60 HU)。10例病人中,4例肿瘤周边强化结节密度降低;6例肿瘤强化部分融合并向中心充填,坏死部分无强化。(2)治疗和病理学检查情况:10例病人均顺利完成肿瘤切除术,肝内和肝门区未见转移。10例病人术后病理学检查结果显示:大体观均为单发肿瘤,肿瘤长径为8.0 cm(4.5~13.5 cm);其中7例肿瘤有完整或不完整假包膜,界限清楚;3例无假包膜,界限不清楚。10例病人肿瘤质地坚硬,切面多呈灰白,鱼肉状,7例肿瘤内见斑片状或点状坏死,3例肿瘤内见小片状或点状出血,其中2例肿瘤内见小斑点状钙化。10例病人镜下见肿瘤组织纵横交错排列,瘤细胞呈梭形,核呈圆形、卵圆形、两端圆钝或细杆样,异型明显,核大深染,可见核分裂。10例病人免疫组织化学染色检测结果示平滑肌肌动蛋白、结蛋白、波形蛋白均呈阳性。(3)随访情况:10例病人术后均获得随访,随访时间为6~130个月,中位随访时间为55个月。10例病人生存时间为10~120个月,中位生存时间为46个月;其中2例分别于术后10个月和11个月因肿瘤复发和远处转移死亡,8例病人生存时间>12个月。结论 PHLMS CT检查平扫结果示边界清楚或不清楚的囊实性肿块,密度不均,CT检查增强扫描结果示肿瘤实质部分和周边持续性不均匀强化。Abstract:Objective To investigate the computed tomography (CT) features of primary liver leiomyosarcoma (PHLMS).Methods The retrospective and descriptive study was conducted. The clinical and imaging data of 10 patients with PHLMS who were admitted to 4 medical centers including 3 cases in Wenzhou Central Hospital, 3 cases in the Second Affiliated Hospital of Wenzhou Medical University, 2 cases in Wenzhou People's Hospital and 2 cases in Yueqing People's Hospital from January 2011 to December 2020 were collected. There were 5 males and 5 females, aged from 41 to 83 years, with a median age of 55 years. All 10 patients underwent abdominal CT examination. Observation indicators: (1) CT features; (2) treatment and pathological examination; (3) follow-up and survival. Follow-up using postoperative outpatient or inpatient examination to detect patient survival was conducted. Patients underwent imaging examination to detect tumor recurrence. Follow-up was up to December 2020. Measurement data with skewed distribution were represented as M (range). Count data were described as absolute numbers.Results (1) CT features: results of CT examination showed that each of the 10 patients had only one single tumor, including 3 cases with tumor on the left lobe of liver and 7 cases with tumor on the right lobe of liver. The tumor diameter of the 10 patients was 8.0 cm(range, 4.5-13.5 cm). Results of plain CT scan of 10 patients showed that 7 cases had tumor in expansive growth as round or oval, with clear boundaries and the tumor parenchyma showing low-density signals and patchy lower density area can be seen in the center, and 3 cases had tumor in infiltrative growth as patchy, with unclear boundaries and the tumor parenchyma showing iso-density signals. The CT scan value of 10 patients was 40 HU(range, 23-47 HU). Results of enhanced CT scan at arterial phase of the 7 cases with tumor in expansive growth showed that 3 cases undergoing tumor parenchyma with uneven mild enhancement signals, 3 cases undergoing tumor parenchyma with uneven moderate enhancement signals and 1 case undergoing tumor parenchyma with uneven significant enhancement signal. The CT scan value of 7 cases was 68 HU(range, 62-88 HU). Results of enhanced CT scan at arterial phase of the 3 cases with tumor in infiltrative growth showed that the peripheral region had high signal than the central region. The CT scan value of 3 cases was 73 HU(range, 67-90 HU). Results of enhanced CT scan at portal vein phase in the 7 cases with tumor in expansive growth showed that the tumor parenchyma showing continuous and progressive mild and moderate enhancement with uneven density, and the CT scan value was 63 HU(range, 55-78 HU). Of the 7 cases, 3 cases showed the enhancement range of tumor parenchyma with the trend of fusion and filling, and 4 cases showed small patchy or nodular enhancement and grid like enhancement in the center and periphery of the tumor. Results of enhanced CT scan at portal vein phase in the 3 cases with tumor in infiltrative growth showed that the enhancement withdrew, the density was uneven, and the CT scan value was 58 HU(range, 50-62 HU). Results of enhanced CT scan at delayed phase in 10 patients showed that the enhancement in the tumor withdrew slowly, and the CT scan value was 53 HU(range, 50-60 HU). Of the 10 patients, 4 cases showed decreased density of enhanced nodules around the tumor and 6 cases showed partially fused and filled to the center of tumor with no enhancement in the necrotic part. (2) Treatment and pathological examination: all 10 patients underwent completed tumor resection successfully, and no metastasis was found in liver or the hilar region. Results of postoperative pathological examination showed that each of the 10 patients had only one single visible tumor with tumor diameter of 8.0 cm(range, 4.5‒13.5 cm). Of the 10 patients, 7 cases had tumor with complete or incomplete pseudocapsule with clear boundary and 3 cases had tumor without pseudocapsule and the boundary was unclear. All 10 patients had tumor with hard parenchyma and the section was mostly gray and fish like. Among them, patchy or punctate necrosis was seen in 7 cases, small patchy or punctate hemorrhage was seen in 3 cases, and small patchy calcification was seen in 2 cases. Microscopically, the tumor tissue was crisscross, the tumor cells were in spindle shaped, the nuclei were in round, oval, blunt at both ends or in thin rod like, with obvious heteromorphism, large and deeply staining, and obviously division. Immunohistochemical staining showed positive staining of smooth muscle actin, desmin and vimentin. (3) Follow-up and survival: all 10 patients were followed up postoperatively for 6 to 130 months, with a median follow-up time of 55 months. The overall survival time of 10 patients were 10 to 120 months, with a median overall survival time of 46 months. Of the 10 patients, 2 cases died of tumor recurrence and distant metastasis 10 and 11 months after operation, respectively and 8 cases survived >12 months.Conclusions Results of plain CT scan of PHLMS show clear or unclear cysts and solid masses with uneven density. Results of enhancement CT scan of PHLMS show persistent uneven enhancement in tumor parenchyma and the surrounding area.